Related Experiment Video
Updated: Aug 9, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Prevention of Stroke
1Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT.
Insights
Elderly patients with atrial fibrillation (AF) face high stroke risks. Anticoagulation, particularly warfarin, offers substantial stroke protection in eligible older adults when managed correctly.
Area of Science:
- Cardiology
- Geriatrics
- Neurology
Background:
- Atrial fibrillation (AF) increases stroke risk, especially in the elderly.
- Comorbidities like hypertension, diabetes, and poor ventricular function further elevate risk.
- Previous transient ischemic attack (TIA) or stroke history is a significant risk factor.
Purpose of the Study:
- To review stroke risk stratification in atrial fibrillation patients.
- To evaluate anticoagulation benefits and alternatives in elderly AF patients.
- To define optimal management targets for anticoagulation therapy.
Main Methods:
- Literature review of stroke risk factors in atrial fibrillation.
- Analysis of anticoagulation efficacy and safety data.
- Evaluation of alternative antiplatelet therapies.
Main Results:
- Elderly patients with AF have a significantly higher risk of stroke.
- Anticoagulation with warfarin, targeting an International Normalized Ratio (INR) of 2.0-3.5, provides substantial benefit.
- Well-controlled blood pressure is crucial for effective anticoagulation.
- Aspirin (325 mg) is an alternative for those unable to use anticoagulants but offers less protection.
Conclusions:
- Anticoagulation is recommended for eligible elderly patients with atrial fibrillation.
- Optimal INR and blood pressure control are essential for maximizing warfarin's benefits.
- Aspirin serves as a less effective alternative when anticoagulation is contraindicated.
Abstract:
Patients with atrial fibrillation are at variable risks for developing a stroke. The risk is significantly increased among the elderly. Other risks factors include hypertension, diabetes, poor ventricular function, and a prior history of TIA or stroke. Among the elderly, it is generally recommended that those patients who are eligible for anticoagulation would benefit substantially from its use provided the INR is maintained between 2.0-3.5 and blood pressure is well controlled. In those patients that cannot be safely anticoagulated, aspirin at a dose of 325 mg is a viable alternative but is likely to offer substantially less protection than warfarin.
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis IV: Nursing Management
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

